Verbal Behavior: Clinical Trials

7 trials for Verbal Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting, 1 terminated. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Recruiting 1, Terminated 1
Phase 21Completed 1

Follow Verbal Behavior: new trials by email Literature Review of Verbal Behavior trials Research Report on Verbal Behavior

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Targets in Spanish and English Bilingual Speech Intervention
Speech Intervention - Speech Sound Disorder
Phase 1RecruitingPhilip Combiths162024-05-082026-11-03
Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors
Visual-acoustic biofeedback, Motor-based treatment - Speech Sound Disorder
Phase 1CompletedNew York University72020-09-012023-02-13
Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors
Visual-acoustic biofeedback, Ultrasound biofeedback - Speech Sound Disorder
Phase 1CompletedNew York University72019-03-012023-12-11
Medication Enhanced Rapid Therapy
d-cycloserine and mifepristone - Anxiety Disorders
Phase 1TerminatedWashington University School of Medicine152014-01-132023-04-26
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Transcranial Direct Current Stimulation - Cathodal stimulation, Transcranial Direct Current Stimulation - Anodal stimulation, Transcranial Direct Current Stimulation - Sham stimulation - Nonfluent Aphasia, Stroke
Phase 1CompletedShirley Ryan AbilityLab122010-03-012017-05-15
Improve Speech Using an In-the-ear Device in Parkinson's Disease
SpeechEasy Model ITC - Parkinson's Disease, Dysarthria
Phase 1CompletedRush University Medical Center402006-06-012013-01-18
Expiratory Muscle Training in Patients With Parkinson's Disease
EMST - Active Treatment, sham EMST - Parkinson's Disease
Phase 1 / Phase 2CompletedUniversity of Florida902004-01-012011-09-20

Narrower conditions

Speech (7)  ·  Speech Sound Disorder (3)  ·  Parkinson Disease (2)  ·  Anxiety Disorders (1)  ·  Aphasia (1)  ·  Aphasia, Broca (1)  ·  Cough (1)  ·  Dysarthria (1)  ·  Ischemic Stroke (1)  ·  Respiratory Aspiration (1)  ·  Speech Intelligibility (1)  ·  Stroke (1)

Broader conditions

Behavior (7)  ·  Communication (7)  ·  Communication Disorders (5)  ·  Mental Disorders (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurodevelopmental Disorders (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Basal Ganglia Diseases (2)  ·  Language Disorders (2)  ·  Movement Disorders (2)  ·  Neurobehavioral Manifestations (2)

Interventions

Cycloserine (1)  ·  Mifepristone (1)  ·  Transcranial Direct Current Stimulation (1)

Sponsors

New York University (2)  ·  Philip Combiths (1)  ·  Rush University Medical Center (1)  ·  Shirley Ryan AbilityLab (1)  ·  University of Florida (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)

Top investigators

Christine M Sapienza, Ph.D. (1)  ·  Emily Wang, PHD (1)  ·  Eric J Lenze, MD (1)  ·  Leo Verhagen, MD, PHD (1)  ·  Leora R Cherney, PhD (1)

Results publications

PMID 19029430, PMID 34232693

NIH funding

R01DC017476 (2), R21DC009876 (1), R21DC021249 (1)